Performance of LLY Eli Lilly and Company | 89.9% in 12m
Compare LLY with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Eli Lilly and Company with its related Sector/Index XLV
Performance Duell LLY vs XLV
| TimeFrame | LLY | XLV |
|---|---|---|
| 1 Day | -1.00% | -0.67% |
| 1 Week | -2.83% | 1.08% |
| 1 Month | -6.24% | -3.66% |
| 3 Months | 15.7% | 1.40% |
| 6 Months | 24.1% | 11.50% |
| 12 Months | 89.9% | 6.44% |
| YTD | 22.6% | 1.19% |
| Rel. Perf. 1m | -0.20 | |
| Rel. Perf. 3m | 1.53 | |
| Rel. Perf. 6m | 1.19 | |
| Rel. Perf. 12m | 5.92 |
Is Eli Lilly and Company a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Eli Lilly and Company is currently (April 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.49 and therefor a neutral outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LLY as of April 2024 is 969.17. This means that LLY is currently undervalued and has a potential upside of +33.7% (Margin of Safety).
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LLY as of April 2024 is 969.17. This means that LLY is currently undervalued and has a potential upside of +33.7% (Margin of Safety).
Is LLY a buy, sell or hold?
- Strong Buy: 15
- Buy: 5
- Hold: 6
- Sell: 2
- Strong Sell: 0
Values above 0%: LLY is performing better - Values below 0%: LLY is underperforming
Compare LLY with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.62% | -3.11% | 2.60% | 64.15% |
| US NASDAQ 100 | QQQ | -3.08% | -1.67% | 2.43% | 52.09% |
| US Dow Jones Industrial 30 | DIA | -3.75% | -3.23% | 7.66% | 74.14% |
| German DAX 40 | DBXD | -3.26% | -4.24% | 3.94% | 77.70% |
| UK FTSE 100 | ISFU | -5.59% | -7.37% | 10.14% | 82.92% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.85% | -6.24% | 22.54% | 102.88% |
| Hongkong Hang Seng | HSI | -9.41% | -5.99% | 27.82% | 108.67% |
| Japan Nikkei 225 | EXX7 | 0.02% | 2.26% | 9.91% | 74.68% |
| India NIFTY 50 | INDA | -5.22% | -9.70% | 3.15% | 58.99% |
| Brasil Bovespa | EWZ | -5.15% | -1.77% | 17.42% | 71.53% |
LLY Eli Lilly and Company vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.14% | -1.85% | 2.99% | 51.23% |
| Consumer Discretionary | XLY | -4.63% | -1.97% | 7.66% | 68.28% |
| Consumer Staples | XLP | -5.58% | -6.66% | 10.88% | 88.39% |
| Energy | XLE | -5.80% | -9.85% | 11.51% | 71.84% |
| Financial | XLF | -5.47% | -5.32% | -4.41% | 62.18% |
| Health Care | XLV | -3.91% | -2.58% | 12.55% | 83.49% |
| Industrial | XLI | -4.30% | -4.68% | -2.36% | 64.14% |
| Materials | XLB | -2.76% | -3.58% | 3.30% | 75.70% |
| Real Estate | XLRE | -4.76% | -0.94% | 8.90% | 87.24% |
| Technology | XLK | -3.35% | -1.00% | 2.59% | 51.56% |
| Utilities | XLU | -6.68% | -10.54% | 9.29% | 90.90% |
| Aerospace & Defense | XAR | -4.72% | -3.26% | 4.98% | 71.45% |
| Biotech | XBI | -1.32% | 5.04% | -1.50% | 87.15% |
| Homebuilder | XHB | -4.59% | 0.21% | -24.22% | 39.22% |
| Retail | XRT | -4.98% | -0.58% | -0.44% | 68.99% |
Does Eli Lilly and Company outperform its market, is LLY a Sector Leader?
Yes, over the last 12 months Eli Lilly and Company (LLY) made 89.93%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.44%.
Over the last 3 months LLY made 15.70%, while XLV made 1.40%.
Yes, over the last 12 months Eli Lilly and Company (LLY) made 89.93%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.44%.
Over the last 3 months LLY made 15.70%, while XLV made 1.40%.
| Period | LLY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -6.24% | -3.66% | -3.13% |
| 3 Months | 15.70% | 1.40% | 3.49% |
| 12 Months | 89.93% | 6.44% | 25.78% |